Age is a prognostic factor even among patients with multiple myeloma younger than 66 years treated with high-dose melphalan: the IFM experience on 2316 patients
即使在接受高剂量美法仑治疗的66岁以下多发性骨髓瘤患者中,年龄也是一个预后因素:IFM对2316例患者的经验
期刊:Haematologica
影响因子:7.9
doi:10.3324/haematol.2013.098608
Chretien, Marie-Lorraine; Hebraud, Benjamin; Cances-Lauwers, Valérie; Hulin, Cyrille; Marit, Gerald; Leleu, Xavier; Karlin, Lionel; Roussel, Murielle; Stoppa, Anne-Marie; Guilhot, Francois; Lamy, Thierry; Garderet, Laurent; Pegourie, Brigitte; Dib, Mamoun; Sebban, Catherine; Lenain, Pascal; Brechignac, Sabine; Royer, Bruno; Wetterwald, Marc; Legros, Laurence; Orsini-Piocelle, Frédérique; Voillat, Laurent; Delbrel, Xavier; Caillot, Denis; Macro, Margaret; Facon, Thierry; Attal, Michel; Moreau, Philippe; Avet-Loiseau, Hervé; Corre, Jill